Catalent
CTLT
#1591
Rank
NZ$18.46 B
Marketcap
$101.71
Share price
1.15%
Change (1 day)
53.85%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2023 (TTM): -$2.09

According to Catalent's latest financial reports the company's current EPS (TTM) is -$2.20. In 2022 the company made an earnings per share (EPS) of $3.87 a decrease over its 2021 EPS that were of $5.57.

EPS history for Catalent from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.09-154.07%
2022$3.87-30.58%
2021$5.5779.67%
2020$3.10114.12%
2019$1.45-15%
2018$1.7075.44%
2017$0.97-22.97%
2016$1.26-59.56%
2015$3.12282.05%
2014$0.82-378.2%
2013-$0.29

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.35-161.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.28-41.86%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.40 9.30%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$10.89-595.35%๐Ÿ‡บ๐Ÿ‡ธ USA